Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: An overview

European Radiology

Volumn 7, Issue 7, 1997, Pages 1103-1109

  Kwekkeboom, D J ^a   Krenning, E P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Neuroendocrine tumors; Octreotide; Receptor scintigraphy; Somatostatin; Somatostatin receptor

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; SDZ 215 811; SDZ 215-811;

HUMAN; IMMUNOLOGY; NEOPLASM; NEUROENDOCRINE TUMOR; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

HUMANS; INDIUM RADIOISOTOPES; NEOPLASMS; NEUROENDOCRINE TUMORS; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030634913     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050262     Document Type: Article

References (37)

1. Patel YC, Amherdt M, Orci L (1982) Quantitative electron microscopic autoradiography of insulin, glucagon and somatostatin binding sites on islets. Science 217: 1155
2. Reubi JC, Maurer R (1985) Autoradiographic mapping of somatostatin receptors in the rat CNS and pituitary. Neuroscience 15: 1183
3. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ (1989) Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem 264: 949
4. Kwekkeboom DJ, Lamberts SWJ, Habbema JDF, Krenning EP (1996) Cost-effectiveness analysis of somatostatin receptor scintigraphy. J Nucl Med 37: 886
5. 123I]SDZ 204-090). J Clin Endocrinol Metab 73: 850
6. Ur E, Mather SJ, Bomanji J, Ellison D, Britton KE, Grossman AB, Wass JAH, Besser GM (1992) Pituitary imaging using a labelled somatostatin analogue in acromegaly. Clin Endocrinol 36: 147
7. Bruin TWA de, Kwekkeboom DJ, Van't Verlaat JW, Reubi JC, Krenning EP, Lamberts SWJ, Croughs RJM (1992) Clinically nonfunctioning pituitary adenoma and octreotide response to long-term high dose treatment, and studies in vitro. J Clin Endocrinol Metab 75: 1310
8. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PPM, Lamberts SWJ (1993) Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med 20: 283
9. 111In-pentetreotide for endocrine gastroenteropancreatic tumors. Horm Metab Res 27 (Suppl): 28
10. 111In-DTPA-D-Phe1]-octreotide. Acta Oncol 32: 783
11. Kwekkeboom DJ, Krenning EP, Oei HY, Eyck CHJ van, Lamberts SWJ (1995) Use of radiolabeled somatostatin to localize islet cell tumors. In: Mignon M, Jensen RT (eds) Frontiers of gastro-intestinal research, vol 23. Endocrine tumors of the pancreas. Karger, New York, pp 298-308
12. Scherübl H, Bäder M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riecken EO, Wiedenmann B (1993) Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. Gastroenterology 105: 1705
13. Zimmer T, Ziegler K, Bäder M, Fett U, Hamm B, Riecken EO, Wiedenmann B (1994) Localisation of neuroendocrine tumours of the upper gastrointestinal tract. Gut 35: 471
14. Joseph K, Stapp J, Reinecke J, Höffken H, Benning R, Neuhaus C, Trautmann ME, Schwerk WB, Arnold R (1992) Rezeptorszintigraphie bei endokrinen gastroentero-pankreatischen Tumoren. Dtsch Med Wochenschr 117: 1025
15. Kerviler E de, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M (1994) Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. Eur J Nucl Med 21: 1191
16. Gibril F, Reynolds JC, Doppman J, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT (1996) Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. Ann Intern Med 125: 26
17. Rösch T, Lightdale CJ, Botet JF, Boyce GA, Sivak MV Jr, Yasuda K, Heyder N, Palazzo L, Dancygier H, Schuhdziarra V, Classen M (1992) Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 326: 1721
18. Lebtahi R, Cadiot G, Sarda L, Kerviler E de, Faraggi M, Sobhani I, Mignon M, Le Guludec D (1994) Clinical interest of Octreoscan 111 scintigraphy in gastroenteropancreatic endocrine tumors. J Nucl Med 35: 96P
19. Weinel RJ, Neuhaus C, Stapp J, Klotter HJ, Trautmann ME, Joseph K, Arnold R, Rothmund M (1993) Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy. Ann Surg 218: 640
20. Lamberts SWJ, Hofland LJ, Koetsveld PM van, Reubi JC, Bruining HA, Bakker WH, Krenning EP (1990) Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors. Consequences with regard to diagnosis, localisation and therapy. J Clin Endocrinol Metab 71: 566
21. Kwekkeboom DJ, Van Urk H, Pauw KH, Lamberts SWJ, Kooij PPM, Hoogma R, Krenning EP (1993) Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med 34: 873
22. Hodge KM, Byers RM, Peters LJ (1988) Paragangliomas of the head and neck. Arch Otolaryngol Head Neck Surg 114: 872
23. Kwekkeboom DJ, Reubi JC, Lamberts SWJ, Bruining HA, Mulder AH, Oei HY, Krenning EP (1993) In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 76: 1413
24. Kwekkeboom DJ, Hoff AM, Lamberts SWJ, Oei HY, Krenning EP (1992) Somatostatin analogue scintigraphy: a simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases. Arch Dermatol 128: 818
25. Hoefnagel CA, Rankin EM, Valdés Olmos, Israëls SP, Pavel S, Janssen AGM (1994) Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide. Eur J Nucl Med 21: 587
26. Kwekkeboom DJ, Kho GS, Lamberts SWJ, Reubi JC, Laissue JA, Krenning EP (1994) The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med 21: 1106
27. Van Eijck CH, Krenning EP, Bootsma A, Oei HY, Pel R van, Jeekel J, Reubi JC, Lamberts SWJ (1994) Somatostatin-receptor scintigraphy in primary breast cancer. Lancet 343: 640
28. Reubi JC, Waser B, Vanhagen M, Lamberts SWJ, Krenning EP, Gebbers JO, Laissue JA (1992) In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 50: 895
29. Vanhagen PM, Krenning EP, Kwekkeboom DJ, Reubi JC, Anker-Lugtenburg PJ van den, Löwenberg B, Lamberts SWJ (1994) Somatostatin and the immune and haematopoetic system; a review. Eur J Clin Invest 24: 91
30. Van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Gerrits CJH, Vanhagen PM, Reubi JC, Lamberts SWJ, Löwenberg B (1994) The role of somatostatin receptor scintigraphy in the initial staging of malignant lymphoma. J Nucl Med 35: 132P
31. Vanhagen PM, Krenning EP, Reubi JC, Kwekkeboom DJ, Bakker WH, Mulder AH, Laissue I, Hoogstede HC, Lamberts SWJ (1994) Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med 21: 497
32. 1]-octreotide scintigraphy in thyroidaal and orbital Graves' disease: a parameter for disease activity? J Clin Endocrinol Metab 79: 1845
33. Chang TC, Kao SCS, Huang KM (1992) Octreotide and Graves' ophthalmopathy and myxoedema. Br Med J 304: 158
34. Krassas GE, Dumas A, Pontikides N, Kaltsas T (1995) Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease. Clin Endocrinol 42: 571
35. 1]-octreotide. A case history. Ann NY Acad Sci 733: 496
36. Krenning EP, Kooij PPM, Pauwels S, Breeman WAP, Postema PTE, Herder WW de, Valkema R, Kwekkeboom DJ. Somatostatin receptor scintigraphy and radionuclide therapy. Digestion (in press)
37. 123I-Tyr-3-]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20: 716